Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity

Research output: Contribution to journalArticle

121 Citations (Scopus)


Background: Adiponectin is an abundantly expressed adipocyte-specific protein, whose level is decreased in obesity, and which appears to be a key participant in developing inflammation, insulin resistance and metabolic syndrome (MetS). We examined whether the relationship between adiponectin and inflammatory markers, insulin resistance and MetS was independent of obesity.Methods and results: The study was performed in 1094 men and women, aged 27–77 years, from a representative community population. We measured serum inflammatory markers, homoeostasis model assessment of insulin resistance (HOMA-IR) and prevalent MetS using National Cholesterol Education Program ATPIII criteria. Sex- and age-adjusted plasma adiponectin concentration was inversely correlated with body mass index (BMI), waist–hip ratio, diastolic blood pressure, triglycerides, glucose and fasting insulin, and positively correlated with HDL cholesterol (all P
Original languageEnglish
Pages (from-to)772-779
JournalInternational Journal of Obesity
Publication statusPublished - 2008


Cite this